Literature DB >> 26588915

Transplantation of kidneys with tumors.

Giovanni M Frascà1, Antonia D'Errico2, Deborah Malvi2, Camillo Porta3, Laura Cosmai4, Matteo Santoni5, Silvio Sandrini6, Chiara Salviani6, Maurizio Gallieni7,8, Emilio Balestra9.   

Abstract

The shortage of donors in the face of the increasing number of patients wait-listed for renal transplantation has prompted several strategies including the use of kidneys with a tumor, whether found by chance on harvesting from a deceased donor or intentionally removed from a living donor and transplanted after excision of the lesion. Current evidence suggests that a solitary well-differentiated renal cell carcinoma, Fuhrman nuclear grade I-II, less than 1 cm in diameter and resected before grafting may be considered at minimal risk of recurrence in the recipient who, however, should be informed of the possible risk and consent to receive such a graft.

Entities:  

Keywords:  Kidney donation; Renal cancer; Renal transplantation; Safety of donation; Tumor transmission

Mesh:

Year:  2015        PMID: 26588915     DOI: 10.1007/s40620-015-0249-2

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  40 in total

1.  Transmission of cancer from organ donors.

Authors:  I Penn
Journal:  Ann Transplant       Date:  1997       Impact factor: 1.530

Review 2.  An update on donor-derived disease transmission in organ transplantation.

Authors:  M G Ison; M A Nalesnik
Journal:  Am J Transplant       Date:  2011-03-28       Impact factor: 8.086

3.  Potential pitfalls in the frozen section evaluation of parenchymal margins in nephron-sparing surgery.

Authors:  Teresa McHale; S Bruce Malkowicz; John E Tomaszewski; Elizabeth M Genega
Journal:  Am J Clin Pathol       Date:  2002-12       Impact factor: 2.493

4.  Donor-transmitted malignancies in organ transplantation: assessment of clinical risk.

Authors:  M A Nalesnik; E S Woodle; J M Dimaio; B Vasudev; L W Teperman; S Covington; S Taranto; J P Gockerman; R Shapiro; V Sharma; L J Swinnen; A Yoshida; M G Ison
Journal:  Am J Transplant       Date:  2011-06       Impact factor: 8.086

5.  The use of neoplastic donors to increase the donor pool.

Authors:  P Fiaschetti; R Pretagostini; D Stabile; D Peritore; A Oliveti; F Gabbrielli; S Cenci; A Ricci; F Vespasiano; W F Grigioni
Journal:  Transplant Proc       Date:  2012-09       Impact factor: 1.066

Review 6.  Efficacy and safety of nephron-sparing surgery.

Authors:  Hein Van Poppel
Journal:  Int J Urol       Date:  2010-04       Impact factor: 3.369

Review 7.  EAU guidelines on renal cell carcinoma: 2014 update.

Authors:  Borje Ljungberg; Karim Bensalah; Steven Canfield; Saeed Dabestani; Fabian Hofmann; Milan Hora; Markus A Kuczyk; Thomas Lam; Lorenzo Marconi; Axel S Merseburger; Peter Mulders; Thomas Powles; Michael Staehler; Alessandro Volpe; Axel Bex
Journal:  Eur Urol       Date:  2015-01-21       Impact factor: 20.096

8.  Living-donor renal transplantation of grafts with incidental renal masses after ex-vivo partial nephrectomy.

Authors:  Alp Sener; Vik Uberoi; Stephen T Bartlett; Andrew C Kramer; Michael W Phelan
Journal:  BJU Int       Date:  2009-07-07       Impact factor: 5.588

9.  Switch to a sirolimus-based immunosuppression in long-term renal transplant recipients: reduced rate of (pre-)malignancies and nonmelanoma skin cancer in a prospective, randomized, assessor-blinded, controlled clinical trial.

Authors:  R Salgo; J Gossmann; H Schöfer; H G Kachel; J Kuck; H Geiger; R Kaufmann; E H Scheuermann
Journal:  Am J Transplant       Date:  2010-02-01       Impact factor: 8.086

Review 10.  Surgical intervention in patients with metastatic renal cancer: metastasectomy and cytoreductive nephrectomy.

Authors:  Paul Russo; Matthew Francis O'Brien
Journal:  Urol Clin North Am       Date:  2008-11       Impact factor: 2.241

View more
  4 in total

1.  How safe are organs from deceased donors with neoplasia? The results of the Italian Transplantation Network.

Authors:  Albino Eccher; Letizia Lombardini; Ilaria Girolami; Francesca Puoti; Gianluigi Zaza; Giovanni Gambaro; Amedeo Carraro; Giovanni Valotto; Luca Cima; Luca Novelli; Desley Neil; Umberto Montin; Aldo Scarpa; Matteo Brunelli; Alessandro Nanni Costa; Antonia D'Errico
Journal:  J Nephrol       Date:  2019-01-02       Impact factor: 3.902

2.  Assessment of Restored Kidney Transplantation Including the Use of Wider Criteria for Accepting Renal Donors After Cancer Excision.

Authors:  Philip Sprott; Adrian D Hibberd; Munish K Heer; Paul R Trevillian; David A Clark; David W Johnson; Christopher Oldmeadow; Simon Chiu; John R Attia
Journal:  Transplant Direct       Date:  2019-10-08

3.  Donor-transmitted cancer in kidney transplant recipients: a systematic review.

Authors:  Albino Eccher; Ilaria Girolami; Jennifer Danielle Motter; Stefano Marletta; Giovanni Gambaro; Rostand Emmanuel Nguefuet Momo; Francesco Nacchia; Paola Donato; Luigino Boschiero; Ugo Boggi; Letizia Lombardini; Massimo Cardillo; Antonietta D'Errico; Desley Neil; Dorry Lidor Segev; Gianluigi Zaza
Journal:  J Nephrol       Date:  2020-06-13       Impact factor: 3.902

4.  Pathological features and outcomes of incidental renal cell carcinoma in candidate solid organ donors.

Authors:  Francesca Ambrosi; Costantino Ricci; Deborah Malvi; Carlo De Cillia; Matteo Ravaioli; Michelangelo Fiorentino; Massimo Cardillo; Francesco Vasuri; Antonia D'Errico
Journal:  Kidney Res Clin Pract       Date:  2020-12-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.